Amplyx Pharmaceuticals
Developing novel, broad-spectrum antifungal agents for the treatment of life-threatening invasive fungal infections due to candida, aspergillus and rare molds. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD289—434m (Dealroom.co estimates May 2020.)
San Diego California (HQ)
Authorizing premium user...